Molina Healthcare, Inc. (NYSE:MOH) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 2.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 458,651 shares of the company's stock after purchasing an additional 11,960 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.80% of Molina Healthcare worth $133,490,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Waldron Private Wealth LLC lifted its stake in shares of Molina Healthcare by 4.7% during the 4th quarter. Waldron Private Wealth LLC now owns 729 shares of the company's stock worth $212,000 after acquiring an additional 33 shares during the last quarter. Angeles Investment Advisors LLC lifted its stake in shares of Molina Healthcare by 5.4% during the 4th quarter. Angeles Investment Advisors LLC now owns 838 shares of the company's stock worth $244,000 after acquiring an additional 43 shares during the last quarter. Coldstream Capital Management Inc. lifted its stake in shares of Molina Healthcare by 2.1% during the 4th quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock worth $683,000 after acquiring an additional 48 shares during the last quarter. Lindbrook Capital LLC lifted its stake in shares of Molina Healthcare by 38.5% during the 4th quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock worth $60,000 after acquiring an additional 57 shares during the last quarter. Finally, Laird Norton Wetherby Wealth Management LLC lifted its stake in shares of Molina Healthcare by 7.1% during the 4th quarter. Laird Norton Wetherby Wealth Management LLC now owns 877 shares of the company's stock worth $255,000 after acquiring an additional 58 shares during the last quarter. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Stock Performance

MOH traded up $0.53 on Thursday, reaching $301.86. 106,409 shares of the stock were exchanged, compared to its average volume of 737,686. The firm has a market capitalization of $16.36 billion, a PE ratio of 14.78, a PEG ratio of 1.06 and a beta of 0.63. The company's 50-day moving average price is $323.92 and its 200 day moving average price is $307.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The company's revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.73 EPS. As a group, sell-side analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Insider Buying and Selling

In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the sale, the chief executive officer now directly owns 257,715 shares in the company, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard M. Schapiro sold 669 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director now owns 11,244 shares of the company's stock, valued at $3,603,702. This trade represents a 5.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 89,169 shares of company stock valued at $28,520,995. 1.10% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Truist Financial lifted their target price on Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research report on Friday, April 11th. Guggenheim began coverage on Molina Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Robert W. Baird reiterated a "neutral" rating and issued a $375.00 price target (up from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Nine analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $365.38.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.